Cell BiologybioRxivPreprint
Glutamine-regulated VCP acetylation creates a proteostasis vulnerability in RB1-deficient tumor
Bing‐Hui Yang, Ying Cao, Yining Tao…·Wei Sun
This study identifies VCP inhibition as a therapeutic strategy for RB1-deficient tumors by revealing glutamine-regulated VCP acetylation as a proteostasis vulnerability.
DOI 10.64898/2026.09.14.751361